Aptamers - Global Market Outlook (2017-2023)

Aptamers - Global Market Outlook (2017-2023)

  • Published: December 2017
  • ID: SMRC16849

According to Stratistics MRC, the Global Aptamers market is expected to grow from $128.80 million in 2016 to reach $408.14 million by 2023 with a CAGR of 17.9%. Rising investments in R&D of biotechnology and pharmaceutical industries, technological advancements and high efficient and cost-reduced process for binding larger molecules as compared to antibodies are the some of the key factors propelling the market growth. However, lack of awareness about the technology in developing economies and inadequate regulatory structure are hampering the market. The increased applications of aptamers in the food and chemicals industries are expected to create huge opportunities for market growth.

By product, the DNA aptamers are expected to have huge potential in the diagnosis and treatment of human disorder. DNA aptamers are generally used for the diagnosis of infectious disorder, cancer and cardiovascular disorder.  DNA aptamers are oligonucleotides that bind to a variety of targets, such as small molecules, oligosaccharides, peptides, proteins, and cells. They are generated by an evolutionary engineering method called SELEX, using an oligonucleotide library with a randomized sequence. Once DNA aptamer sequences are obtained by SELEX, the aptamers can be chemically synthesized on a large GMP scale, for diagnostic and therapeutic applications.

Geographically, North America holds the largest market shareduring the forecast period. Technological advancements, huge investments in R&D and developments in Aptamers are the major factors contributing to the growth of the market in this region.

Some of the key players in the Aptamers market are Aptamer Solutions Ltd, Somalogic, Inc., Vivonics, Inc, Aptus Biotech S.L, Base Pair Biotechnologies, Inc, Aptagen, LLC , Trilink Biotechnologies, Inc, Aptamer Sciences Inc, Neoventures Biotechnology Inc, Am Biotechnologies, LLC, NOXXON Pharma, Ophthotech Corporation , Novartis AG, NeoNeuro SAS  and Apta Targets.

Applications Covered:
• Research and Development
• Forensics
• Cancer
• Diagnostics
• Therapeutics Development
• Biodefense
• Other Applications

End Users Covered:
• Contract Research Organizations
• Academic and Government Research Institutes
• Biotechnology and Pharmaceutical Companies
• Other End Users

Aptamers Types Covered:
• Peptide Aptamers
• Nucleic Acid Aptamers

Technologies Covered:
• SELEX
• Other Technologies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary 
   
2 Preface  

 2.1 Abstract 
 2.2 Stake Holders
 2.3 Research Scope
 2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
 2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions
   
3 Market Trend Analysis
 3.1 Introduction
 3.2 Drivers 
 3.3 Restraints
 3.4 Opportunities
 3.5 Threats 
 3.6 Application Analysis
 3.7 End User Analysis
 3.8 Technology Analysis
 3.9 Emerging Markets
 3.10 Futuristic Market Scenario
   
4 Porters Five Force Analysis
 4.1 Bargaining power of suppliers
 4.2 Bargaining power of buyers
 4.3 Threat of substitutes
 4.4 Threat of new entrants
 4.5 Competitive rivalry
   
5 Global Aptamers Market, By Application
 5.1 Introduction
 5.2 Research and Development
  5.2.1 Targeted Drug Delivery
  5.2.2 Drug Discovery and Development
 5.3 Forensics 
 5.4 Cancer 
 5.5 Diagnostics 
  5.5.1 Molecular Imaging
  5.5.2 Biomarker Detection and Discovery
 5.6 Therapeutics Development
 5.7 Biodefense
 5.8 Other Applications
  5.8.1 Food Safety
  5.8.2 Biosensors
   
6 Global Aptamers Market, By End User
 6.1 Introduction
 6.2 Contract Research Organizations
 6.3 Academic and Government Research Institutes
 6.4 Biotechnology and Pharmaceutical Companies
 6.5 Other End Users
   
7 Global Aptamers Market, By Aptamers Type
 7.1 Introduction
 7.2 Peptide Aptamers
 7.3 Nucleic Acid Aptamers
  7.3.1 RNA-Based Aptamers
  7.3.2 XNA-Based Aptamers
  7.3.3 DNA-Based Aptamers
   
8 Global Aptamers Market, By Technology
 8.1 Introduction
 8.2 SELEX  
 8.3 Other Technologies
   
9 Global Aptamers Market, By Geography
 9.1 Introduction
 9.2 North America
  9.2.1 US
  9.2.2 Canada
  9.2.3 Mexico
 9.3 Europe 
  9.3.1 Germany
  9.3.2 UK
  9.3.3 Italy
  9.3.4 France
  9.3.5 Spain
  9.3.6 Rest of Europe
 9.4 Asia Pacific
  9.4.1 Japan
  9.4.2 China
  9.4.3 India
  9.4.4 Australia
  9.4.5 New Zealand
  9.4.6 South Korea
  9.4.7 Rest of Asia Pacific
 9.5 South America
  9.5.1 Argentina
  9.5.2 Brazil
  9.5.3 Chile
  9.5.4 Rest of South America
 9.6 Middle East & Africa
  9.6.1 Saudi Arabia
  9.6.2 UAE
  9.6.3 Qatar
  9.6.4 South Africa
  9.6.5 Rest of Middle East & Africa
   
10 Key Developments 
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
 10.2 Acquisitions & Mergers
 10.3 New Product Launch
 10.4 Expansions
 10.5 Other Key Strategies
   
11 Company Profiling 
 11.1 Aptamer Solutions Ltd.
 11.2 Somalogic, Inc. 
 11.3 Vivonics, Inc. 
 11.4 Aptus Biotech S.L.
 11.5 Base Pair Biotechnologies, Inc.
 11.6 Aptagen, LLC 
 11.7 Trilink Biotechnologies, Inc.
 11.8 Aptamer Sciences Inc.
 11.9 Neoventures Biotechnology Inc.
 11.10 Am Biotechnologies, LLC
 11.11 NOXXON Pharma
 11.12 Ophthotech Corporation
 11.13 Novartis AG
 11.14 NeoNeuro SAS
 11.15 Optech Biotech


List of Tables  
1 Global Aptamers Market Outlook, By Region (2015-2023) (US $MN)
2 Global Aptamers Market Outlook, By Application (2015-2023) (US $MN)
3 Global Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
4 Global Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
5 Global Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
6 Global Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
7 Global Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
8 Global Aptamers Market Outlook, By Diagnostics  (2015-2023) (US $MN)
9 Global Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
10 Global Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
11 Global Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
12 Global Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
13 Global Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
14 Global Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
15 Global Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
16 Global Aptamers Market Outlook, By End User (2015-2023) (US $MN)
17 Global Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
18 Global Aptamers Market Outlook, By Academic and Government Research Institutes  (2015-2023) (US $MN)
19 Global Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
20 Global Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
21 Global Aptamers Market Outlook, By Aptamers Type  (2015-2023) (US $MN)
22 Global Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
23 Global Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
24 Global Aptamers Market Outlook, By RNA-Based Aptamers  (2015-2023) (US $MN)
25 Global Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
26 Global Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
27 Global Aptamers Market Outlook, By Technology  (2015-2023) (US $MN)
28 Global Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
29 Global Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
30 North America Aptamers Market Outlook, By Country (2015-2023) (US $MN)
31 North America Aptamers Market Outlook, By Application (2015-2023) (US $MN)
32 North America Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
33 North America Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
34 North America Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
35 North America Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
36 North America Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
37 North America Aptamers Market Outlook, By Diagnostics  (2015-2023) (US $MN)
38 North America Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
39 North America Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
40 North America Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
41 North America Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
42 North America Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
43 North America Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
44 North America Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
45 North America Aptamers Market Outlook, By End User (2015-2023) (US $MN)
46 North America Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
47 North America Aptamers Market Outlook, By Academic and Government Research Institutes  (2015-2023) (US $MN)
48 North America Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
49 North America Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
50 North America Aptamers Market Outlook, By Aptamers Type  (2015-2023) (US $MN)
51 North America Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
52 North America Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
53 North America Aptamers Market Outlook, By RNA-Based Aptamers  (2015-2023) (US $MN)
54 North America Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
55 North America Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
56 North America Aptamers Market Outlook, By Technology  (2015-2023) (US $MN)
57 North America Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
58 North America Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
59 Europe Aptamers Market Outlook, By Country (2015-2023) (US $MN)
60 Europe Aptamers Market Outlook, By Application (2015-2023) (US $MN)
61 Europe Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
62 Europe Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
63 Europe Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
64 Europe Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
65 Europe Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
66 Europe Aptamers Market Outlook, By Diagnostics  (2015-2023) (US $MN)
67 Europe Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
68 Europe Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
69 Europe Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
70 Europe Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
71 Europe Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
72 Europe Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
73 Europe Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
74 Europe Aptamers Market Outlook, By End User (2015-2023) (US $MN)
75 Europe Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
76 Europe Aptamers Market Outlook, By Academic and Government Research Institutes  (2015-2023) (US $MN)
77 Europe Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
78 Europe Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
79 Europe Aptamers Market Outlook, By Aptamers Type  (2015-2023) (US $MN)
80 Europe Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
81 Europe Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
82 Europe Aptamers Market Outlook, By RNA-Based Aptamers  (2015-2023) (US $MN)
83 Europe Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
84 Europe Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
85 Europe Aptamers Market Outlook, By Technology  (2015-2023) (US $MN)
86 Europe Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
87 Europe Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
88 Asia Pacific Aptamers Market Outlook, By Country (2015-2023) (US $MN)
89 Asia Pacific Aptamers Market Outlook, By Application (2015-2023) (US $MN)
90 Asia Pacific Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
91 Asia Pacific Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
92 Asia Pacific Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
93 Asia Pacific Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
94 Asia Pacific Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
95 Asia Pacific Aptamers Market Outlook, By Diagnostics  (2015-2023) (US $MN)
96 Asia Pacific Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
97 Asia Pacific Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
98 Asia Pacific Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
99 Asia Pacific Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
100 Asia Pacific Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
101 Asia Pacific Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
102 Asia Pacific Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
103 Asia Pacific Aptamers Market Outlook, By End User (2015-2023) (US $MN)
104 Asia Pacific Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
105 Asia Pacific Aptamers Market Outlook, By Academic and Government Research Institutes  (2015-2023) (US $MN)
106 Asia Pacific Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
107 Asia Pacific Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
108 Asia Pacific Aptamers Market Outlook, By Aptamers Type  (2015-2023) (US $MN)
109 Asia Pacific Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
110 Asia Pacific Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
111 Asia Pacific Aptamers Market Outlook, By RNA-Based Aptamers  (2015-2023) (US $MN)
112 Asia Pacific Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
113 Asia Pacific Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
114 Asia Pacific Aptamers Market Outlook, By Technology  (2015-2023) (US $MN)
115 Asia Pacific Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
116 Asia Pacific Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
117 South America Aptamers Market Outlook, By Country (2015-2023) (US $MN)
118 South America Aptamers Market Outlook, By Application (2015-2023) (US $MN)
119 South America Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
120 South America Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
121 South America Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
122 South America Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
123 South America Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
124 South America Aptamers Market Outlook, By Diagnostics  (2015-2023) (US $MN)
125 South America Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
126 South America Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
127 South America Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
128 South America Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
129 South America Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
130 South America Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
131 South America Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
132 South America Aptamers Market Outlook, By End User (2015-2023) (US $MN)
133 South America Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
134 South America Aptamers Market Outlook, By Academic and Government Research Institutes  (2015-2023) (US $MN)
135 South America Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
136 South America Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
137 South America Aptamers Market Outlook, By Aptamers Type  (2015-2023) (US $MN)
138 South America Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
139 South America Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
140 South America Aptamers Market Outlook, By RNA-Based Aptamers  (2015-2023) (US $MN)
141 South America Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
142 South America Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
143 South America Aptamers Market Outlook, By Technology  (2015-2023) (US $MN)
144 South America Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
145 South America Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)
146 Middle East & Africa Aptamers Market Outlook, By Country (2015-2023) (US $MN)
147 Middle East & Africa Aptamers Market Outlook, By Application (2015-2023) (US $MN)
148 Middle East & Africa Aptamers Market Outlook, By Research and Development (2015-2023) (US $MN)
149 Middle East & Africa Aptamers Market Outlook, By Targeted Drug Delivery (2015-2023) (US $MN)
150 Middle East & Africa Aptamers Market Outlook, By Drug Discovery and Development (2015-2023) (US $MN)
151 Middle East & Africa Aptamers Market Outlook, By Forensics (2015-2023) (US $MN)
152 Middle East & Africa Aptamers Market Outlook, By Cancer (2015-2023) (US $MN)
153 Middle East & Africa Aptamers Market Outlook, By Diagnostics  (2015-2023) (US $MN)
154 Middle East & Africa Aptamers Market Outlook, By Molecular Imaging (2015-2023) (US $MN)
155 Middle East & Africa Aptamers Market Outlook, By Biomarker Detection and Discovery (2015-2023) (US $MN)
156 Middle East & Africa Aptamers Market Outlook, By Therapeutics Development (2015-2023) (US $MN)
157 Middle East & Africa Aptamers Market Outlook, By Biodefense (2015-2023) (US $MN)
158 Middle East & Africa Aptamers Market Outlook, By Other Applications (2015-2023) (US $MN)
159 Middle East & Africa Aptamers Market Outlook, By Food Safety (2015-2023) (US $MN)
160 Middle East & Africa Aptamers Market Outlook, By Biosensors (2015-2023) (US $MN)
161 Middle East & Africa Aptamers Market Outlook, By End User (2015-2023) (US $MN)
162 Middle East & Africa Aptamers Market Outlook, By Contract Research Organizations (2015-2023) (US $MN)
163 Middle East & Africa Aptamers Market Outlook, By Academic and Government Research Institutes  (2015-2023) (US $MN)
164 Middle East & Africa Aptamers Market Outlook, By Biotechnology and Pharmaceutical Companies (2015-2023) (US $MN)
165 Middle East & Africa Aptamers Market Outlook, By Other End Users (2015-2023) (US $MN)
166 Middle East & Africa Aptamers Market Outlook, By Aptamers Type  (2015-2023) (US $MN)
167 Middle East & Africa Aptamers Market Outlook, By Peptide Aptamers (2015-2023) (US $MN)
168 Middle East & Africa Aptamers Market Outlook, By Nucleic Acid Aptamers (2015-2023) (US $MN)
169 Middle East & Africa Aptamers Market Outlook, By RNA-Based Aptamers  (2015-2023) (US $MN)
170 Middle East & Africa Aptamers Market Outlook, By XNA-Based Aptamers (2015-2023) (US $MN)
171 Middle East & Africa Aptamers Market Outlook, By DNA-Based Aptamers (2015-2023) (US $MN)
172 Middle East & Africa Aptamers Market Outlook, By Technology  (2015-2023) (US $MN)
173 Middle East & Africa Aptamers Market Outlook, By SELEX (2015-2023) (US $MN)
174 Middle East & Africa Aptamers Market Outlook, By Other Technologies (2015-2023) (US $MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials